We report a case of severe post partum cadiomyopathy in severe cardiogenic shock, treated successfully and urgently with the implantation of Left Ventricular Assist device. The patient recovered a normal left ventricle function shortly after implantation. This case illustrates the crucial place of left ventricular assist device in severe post partum cardiomyopathy as a bridge to recovery as well as a bridge to transplantation.
References
[1]
S. Gevaert, Y. Van Belleghem, S. Bouchez, Herck, F. De Somer, Y. De Block, F. Tromp, E. Vandecasteele, F. Martens and M. De Pauw, “Acute and Critically Ill Peripartum Cardiomyopathy and ‘Bridge to’ Therapeutic Options: A Single Center Experience with Intra-Aortic Balloon Pump, Extra Corporeal Membrane Oxygenation and Continuous-Flow Left Ventricular Assist Devices,” Critical Care, Vol. 15, No. 2, 2011, p. R93.
doi:10.1186/cc10098
[2]
J. G. Demakis and S. H. Rahimtoola, “Peripartum Cardiomyopathy,” Circulation, Vol. 44, No. 5, 1971, pp. 964-968. doi:10.1161/01.CIR.44.5.964
[3]
A. M. Amos, W. A. Jaber and S. D. Russell, “Improved Outcomes in Peripartum Cardiomyopathy with Contemporary,” American Heart Journal, Vol. 152, No. 3, 2006, pp. 509-513. doi:10.1016/j.ahj.2006.02.008
[4]
J. D. Fett, A. A. Ansari, J. B. Sundstrom and G. F. Combs, “Peripartum Cardiomyopathy: A Selenium Disconnection and an Autoimmune Connection,” International Journal of Cardiology, Vol. 86, No. 2-3, 2002, pp. 311-316.
doi:10.1016/S0167-5273(02)00359-5
[5]
J. Abboud, Y. Murad, C. Chen-Scarabelli, L. Saravolatz and T. M. Scarabelli, “Peripartum Cardiomyopathy: A Comprehensive Review,” International Journal of Cardiology, Vol. 118, No. 3, 2007, pp. 295-303.
doi:10.1016/j.ijcard.2006.08.005
[6]
M. Diao, I. B. Diop and A. Kane, “Electrocardiographic Recording of Long Duration (Holter) of 24 Hours during Idiopathic Cardiomyopathy of the Peripartum,” Archives des Maladies du Coeur et des Vaisseaux, Vol. 97, No. 1, 2004, pp. 25-30.
[7]
E. V. Potapov, T. Krabatsch, H. O. Ventura and R. Hetzer, “Advances in Mechanical Circulatory Support: Year in Review,” Journal of Heart and Lung Transplantation, Vol. 30, No. 5, 2011, pp. 487-493.
doi:10.1016/j.healun.2011.01.703
[8]
E. V. Potapov, A. Stepanenko, M. Dandel, M. Kukucka, H. B. Lehmkuhl, Y. Weng, F. Hennig, T. Krabatsch and R. Hetzer, “Tricuspid Incompetence and Geometry of the Right Ventricle as Predictors of Right Ventricular Function after Implantation of a Left Ventricular Assist Device,” Journal of Heart and Lung Transplantation, Vol. 27, No. 12, 2008, pp. 1275-1281.
doi:10.1016/j.healun.2008.08.012
[9]
E. V. Potapov, M. Schweiger, A. Stepanenko, M. Dandel, M. Kukucka, J. Vierecke, R. Hetzer and T. Krabatsch, “Tricuspid Valve Repair in Patients Supported with Left Ventricular Assist Devices,” ASAIO Journal, Vol. 57, No. 5, 2011, pp. 363-367.
doi:10.1097/01.MAT.0000398944.12757.eb
[10]
E. V. Potapov, A. Stepanenko, T. Krabatsch and R. Hetzer, “Managing Long-Term Complications of Left Ven- tricular Assist Device Therapy: Review,” Current Opinion in Cardiology, Vol. 26, No. 3, 2011, pp. 237-244.
doi:10.1097/HCO.0b013e328345af80
[11]
J. Cowger, F. D. Pagani, J. W. Haft, et al., “The Development of Aortic Insufficiency in Left Ventricular Assist Device-Supported Patients,” Circulation: Heart Failure, Vol. 3, 2010, pp. 668-674.
doi:10.1161/CIRCHEARTFAILURE.109.917765
[12]
M. S. Slaughter, F. D. Pagani, J. G. Rogers, et al., “Clinical Management of Continuous-Flow Left Ventricular Assist Devices in Advanced Heart Failure,” Journal of Heart and Lung Transplantation, Vol. 9, No. 4S, 2010, pp. S1-S39. doi:10.1016/j.healun.2010.01.011
[13]
S. Crow, D. Chen, C. Milano 3rd, et al., “Acquired von Willebrand Syndrome in Continuous-Flow Ventricular Assist Device Recipients,” The Annals of Thoracic Surgery, Vol. 90, No. 4, 2010, pp. 1263-1269.
doi:10.1016/j.athoracsur.2010.04.099
[14]
G. V. Letsou, N. Shah, I. D. Gregoric, et al., “Gastrointestinal Bleeding from Arteriovenous Malformations in Patients Supported by the Jarvik 2000 Axial-Flow Left Ventricular Assist Device,” Journal of Heart and Lung Transplantation, Vol. 24, No. 1, 2005, pp. 105-109.
doi:10.1016/j.healun.2003.10.018
[15]
C. Heilmann, U. Geisen, C. Benk, et al., “Haemolysis in Patients with Ventricular Assist Devices: Major Differences between Systems,” European Journal Cardio-Thoracic Surgery, Vol. 36, No. 3, 2009, pp. 580-584.
doi:10.1016/j.ejcts.2009.04.015
[16]
A. Zierer, S. J. Melby, R. K. Voeller, et al., “Late-Onset Driveline Infections: The Achilles’ Heel of Prolonged Left Ventricular Assist Device Support,” The Annals of Thoracic Surgery, Vol. 84, No. 2, 2007, pp. 515-520.
doi:10.1016/j.athoracsur.2007.03.085
[17]
K. Tigges-Limmer, M. Schonbrodt, D. Roefe, et al., “Suicide after Ventricular Assist Device Implantation,” Journal of Heart and Lung Transplantation, Vol. 29, No. 6, 2010, pp. 692-694. doi:10.1016/j.healun.2009.12.005
[18]
L. OOSTEROM, N. DE JONGE, J. KIRKELS AND C. KL?PPING, “LAHPOR. LEFT VENTRICULAR ASSIST DEVICE AS A BRIDGE TO RECOVERY IN A YOUNG WOMAN ADMITTED WITH PERIPARTUM CARDIOMYOPATHY,” NETHERLANDS HEART JOURNAL, VOL. 16, NO. 12, 2008, PP. 426-428.
[19]
D. Mancini, A. Beniaminovitz, H. Levin, K. Catanese, M. Flannery, M. DiTullio, et al., “Low Incidence of Myocardial Recovery after Left Ventricular Assist Device Implantation in Patients with Chronic Heart Failure,” Circulation, Vol. 98, 1998, pp. 2383-2389.
doi:10.1161/01.CIR.98.22.2383
[20]
E. Birks, P. Tansley, J. Hardy, R. George, C. Bowles, M. Burke, et al., “Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure,” The New England Journal of Medicine, Vol. 355, No. 18, 2006, pp. 1873-1884. doi:10.1056/NEJMoa053063
[21]
S. Maybaum, D. Mancini, S. Xydas, R. Starling, K. Aaronson, F. Pagani, et al., “Cardiac Improvement during Mechanical Circulatory Support/A Prospective Multi Center Study of the LVAD Working Group,” Circulation, Vol. 115, No. 19, 2007, pp. 2497-2505.
doi:10.1161/CIRCULATIONAHA.106.633180
[22]
M. Simon, R. Kormos, S. Murali, P. Mair, M. Heffernan, J. Gorcsan, et al., “Myocardial Recovery Using Ventricular Assist Devices/Prevalence, Clinical Characteristics, and Outcomes,” Circulation, Vol. 112, No. S1, 2005, pp. I-32-I-36.
[23]
M. Dandel, Y. Weng, H. Siniawski, A. Stepanenko, T. Krabatsch, E. Potapov, H. Lehmkuhl, C. Knosalla and R. Hetzer, “Heart Failure Reversal by Ventricular Unloading in Patients with Chronic Cardiomyopathy: Criteria for Weaning from Ventricular Assist Devices,” European Heart Journal, Vol. 32, No. 9, 2011, pp. 1148-1160.
doi:10.1093/eurheartj/ehq353
